World Connect News
[ad_1]
These days in the Indian stock market, such tremendous movement and rise is being seen in some selected shares, which is surprising the investors as well as making them rich. The stormy bullish trend going on in the shares of pharma sector giant Novartis India Limited for the last few days has created a stir in the market. On Wednesday, September 9, 2026, the company’s shares continued to rise strongly for the eighth consecutive trading session and touched the maximum limit and reached a huge upper circuit of 20 percent. With this spectacular surge, the share of Novartis India has reached its latest and historical record level of Rs 2,186.40 per share. Due to this continuous rise in the last eight consecutive sessions, there has been a huge increase in the wealth of the investors and the stock has gone up by 47.1 percent overall. This single-day jump of 20 percent recorded on Wednesday is the biggest and tremendous rise in this stock since February 2026. If we look at the data of the last one month, investors have got an excellent return of 36.02 percent in the shares of Novartis India. Let us know in detail what are the main reasons behind this sudden boom and upper circuit and what major corporate changes are going to happen in the company.
The 20 percent upper circuit in the shares of Novartis India on Wednesday has brought back the same memories that were seen in the past in February 2026. On February 20, 2026 also, a similar stormy rise of 20 percent was recorded in this stock. During that time, the company’s original promoter Novartis AG had taken a big decision to sell its huge stake in India. Under the agreement, Novartis AG had formally agreed to sell its majority stake of 70.68 percent in the company to a strong investor group led by ChrysCapital. Under this big strategic deal, a provision was made to sell a total of 1.74 crore shares to investors like Waverise Investments, Chryscapital Fund X and Two Infinity Partners. Ever since the news of this deal came out, heavy buying is being seen continuously on this counter in the stock market.
Experts keeping an eye on the developments related to Novartis India Limited and this big acquisition deal say that after the completion of this deal, there is going to be a big change in the ownership structure of the company. After completion of the deal process, parent company Novartis AG will no longer be the promoter of Novartis India. Instead, the new investor group buying the stake will take complete control of the company and will become its new promoter. As per the terms and conditions, the name of Novartis India will also be completely changed within exactly 120 days of the completion of this acquisition, so that the new name does not contain any reference or association with the Novartis Group. Market experts believe that due to this major change in ownership and corporate restructuring, the confidence of investors in this company is continuously strengthening, due to which the shares are continuously hitting upper circuits.
Meanwhile, if we talk about other business developments related to the company, another big change was seen last month. Dr. Reddy’s Laboratories, another major pharma giant of the country, had ended the existing agreement with Novartis India related to the distribution and promotion of some of its selected medicines. Market analysts believe that this decision has been taken mainly due to the change in controlling stake in Novartis India and strategic decisions of the new management. However, despite this agreement ending, the company has taken a huge step on another front. This week, the Board of Directors of Novartis India has given its approval to purchase the popular brand ‘Minipress’ within India and the Minipress trademark as well as all intellectual property rights related to it from Pfizer.
The total financing cost of the deal being undertaken by Novartis India to acquire Minipress and its trademark rights from Pfizer is estimated to be around Rs 1,250 crore. Since the company’s board gave the green signal to this huge investment, it has sent a positive message to investors that the new management is moving forward with a very aggressive and clear strategy for strengthening the company’s portfolio and future growth. Acquiring the rights of an established and strong brand like Minipress will further strengthen the company’s domestic business and increase its market share. This is the reason that amidst all the corporate movements and major changes, investors have rushed to buy this stock, due to which it has seen an upper circuit of 20 percent for the eighth consecutive session. Market experts believe that in the coming days, when this acquisition will completely hit the ground running, even greater improvement in the financial performance of the company may be seen, however, investors should exercise full caution at their level before investing in such rapidly fluctuating stocks.